Standard

Cancer treatment and cardiovascular toxity : Pathogenesis and actual approaches to the diagnosis of heart failure in cancer patients. / Obrezan, A. G.; Shcherbakova, N. V.

In: Voprosy Onkologii, Vol. 65, No. 2, 01.01.2019, p. 172-180.

Research output: Contribution to journal › Article › peer-review

Harvard

Obrezan, AG & Shcherbakova, NV 2019, 'Cancer treatment and cardiovascular toxity: Pathogenesis and actual approaches to the diagnosis of heart failure in cancer patients', Voprosy Onkologii, vol. 65, no. 2, pp. 172-180.

APA

Obrezan, A. G., & Shcherbakova, N. V. (2019). Cancer treatment and cardiovascular toxity: Pathogenesis and actual approaches to the diagnosis of heart failure in cancer patients. Voprosy Onkologii, 65(2), 172-180.

Vancouver

Obrezan AG, Shcherbakova NV. Cancer treatment and cardiovascular toxity: Pathogenesis and actual approaches to the diagnosis of heart failure in cancer patients. Voprosy Onkologii. 2019 Jan 1;65(2):172-180.

Author

Obrezan, A. G. ; Shcherbakova, N. V. / Cancer treatment and cardiovascular toxity : Pathogenesis and actual approaches to the diagnosis of heart failure in cancer patients. In: Voprosy Onkologii. 2019 ; Vol. 65, No. 2. pp. 172-180.

BibTeX

@article{14cb3cca9f1c4021a2b72fc8f6eaf871,
title = "Cancer treatment and cardiovascular toxity: Pathogenesis and actual approaches to the diagnosis of heart failure in cancer patients",
abstract = "The field of cardio-oncology has received increasing attention in recent years. This is due to the fact that the results of a large number of clinical studies on antitumor therapy, covering issues treatments side effects, including associated cardiovascular pathology, are published. Advances in treatment have led to improved survival of patients with cancer, but have also increased clinical significance of treatment side effects. Myocardium, having high metabolic activity, responds to substrate and energy imbalance under the action of increasing malignancy and toxic effects of radio- or chemotherapy. Finding of baseline risk factors, timely identification of cardiovascular diseases, ability to predict the long-term consequences of cancer treatment-associated cardiovascular side effects lead to improving of the prognosis and quality of life, avoiding of over-diagnosis cardiovascular diseases and inappropriating violation of life-saving treatment of a malignant tumor.",
author = "Obrezan, {A. G.} and Shcherbakova, {N. V.}",
year = "2019",
month = jan,
day = "1",
language = "English",
volume = "65",
pages = "172--180",
journal = "Вопросы онкологии",
issn = "0507-3758",
publisher = "Медицина",
number = "2",

}

RIS

TY - JOUR

T1 - Cancer treatment and cardiovascular toxity

T2 - Pathogenesis and actual approaches to the diagnosis of heart failure in cancer patients

AU - Obrezan, A. G.

AU - Shcherbakova, N. V.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The field of cardio-oncology has received increasing attention in recent years. This is due to the fact that the results of a large number of clinical studies on antitumor therapy, covering issues treatments side effects, including associated cardiovascular pathology, are published. Advances in treatment have led to improved survival of patients with cancer, but have also increased clinical significance of treatment side effects. Myocardium, having high metabolic activity, responds to substrate and energy imbalance under the action of increasing malignancy and toxic effects of radio- or chemotherapy. Finding of baseline risk factors, timely identification of cardiovascular diseases, ability to predict the long-term consequences of cancer treatment-associated cardiovascular side effects lead to improving of the prognosis and quality of life, avoiding of over-diagnosis cardiovascular diseases and inappropriating violation of life-saving treatment of a malignant tumor.

AB - The field of cardio-oncology has received increasing attention in recent years. This is due to the fact that the results of a large number of clinical studies on antitumor therapy, covering issues treatments side effects, including associated cardiovascular pathology, are published. Advances in treatment have led to improved survival of patients with cancer, but have also increased clinical significance of treatment side effects. Myocardium, having high metabolic activity, responds to substrate and energy imbalance under the action of increasing malignancy and toxic effects of radio- or chemotherapy. Finding of baseline risk factors, timely identification of cardiovascular diseases, ability to predict the long-term consequences of cancer treatment-associated cardiovascular side effects lead to improving of the prognosis and quality of life, avoiding of over-diagnosis cardiovascular diseases and inappropriating violation of life-saving treatment of a malignant tumor.

UR - http://www.scopus.com/inward/record.url?scp=85082132087&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85082132087

VL - 65

SP - 172

EP - 180

JO - Вопросы онкологии

JF - Вопросы онкологии

SN - 0507-3758

IS - 2

ER -

ID: 53263182